| Literature DB >> 31787937 |
Sirirak Supa-Amornkul1, Paninee Mongkolsuk2, Pijug Summpunn3, Pongkorn Chaiyakunvat4, Warisara Navaratdusit4, Chutima Jiarpinitnun4, Soraya Chaturongakul2.
Abstract
This study examines treatments of the bacterial pathogen Staphylococcus aureus, namely, in the context of its being a major cause of subclinical bovine mastitis. Such infections caused by S. aureus among dairy cows are difficult to detect and can easily become chronic, leading to reduced productivity and large losses for dairy manufacturers. In this study, the role of alternative sigma factor B (σB), which has been shown to be a global regulator for S. aureus infections, was explored in a mastitis-causing S. aureus strain, RF122. For comparison with the wild-type strain, a sigB null (ΔsigB) mutant was constructed and analyzed for its phenotypes and transcriptome. Our study found that σB is essential for biofilm formation as the ΔsigB mutant strain produced significantly less biofilm than did the wild-type strain at 48 h. σB is involved in response to H2O2 stress. However, σB plays a minor or no role in resistance to antiseptics (e.g., povidone-iodine and chlorhexidine), resistance to tested antibiotics, hemolysin activity, and invasion ability. RNA sequencing identified 225 σB-dependent genes, of which 171 are positively regulated and 54 are negatively regulated. The identified genes are involved in stress response, pathogenesis, and metabolic mechanisms. Quantitative TaqMan RT-PCR was performed to verify the RNA sequencing results; i.e., σB is a positive regulator for asp23, sarA, katA, yabJ, sodA, SAB2006c, and nrdD expressions. In the RF122 strain, σB plays a role in biofilm formation, general stress response (e.g., H2O2), and regulation of virulence factors and virulence-associated genes.Entities:
Keywords: Staphylococcus aureus; alternative sigma factor B; bacterial stress response; staphylococcal bovine mastitis; transcriptome
Year: 2019 PMID: 31787937 PMCID: PMC6853994 DOI: 10.3389/fmicb.2019.02493
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Growth curves of Staphylococcus aureus RF122 and ΔsigB mutant strains. (A) Relationship between OD600 of each strain and time of incubation. (B) Relationship between log10 colony-forming units (CFU) per milliliter of each strain and time of incubation. The experiment was performed in three biological replicates.
Number for σB-regulated genes in each functional class.
| 1 | DNA metabolism | 73 | 1 | 1.37 |
| 2 | Unknown function | 68 | 3 | 4.41 |
| 3 | Mobile and extrachromosomal element functions | 135 | 7 | 5.19 |
| 4 | Regulatory functions | 90 | 5 | 5.56 |
| 5 | Biosynthesis of cofactors, prosthetic groups, and carriers | 36 | 3 | 8.33 |
| 6 | Hypothetical proteins | 748 | 68 | 8.96 |
| 7 | Energy metabolism | 139 | 14 | 10.07 |
| 8 | Transcription | 19 | 2 | 10.53 |
| 9 | Cell envelope | 358 | 44 | 12.29 |
| 10 | Transport and binding proteins | 188 | 25 | 13.30 |
| 11 | Cellular | 100 | 15 | 15.00 |
| 12 | Amino acid biosynthesis | 53 | 12 | 18.87 |
| 13 | Fatty acid and phospholipid metabolism | 36 | 7 | 19.44 |
| 14 | Cellular processes | 54 | 12 | 22.22 |
| 15 | Purines, pyrimidines, nucleosides, and nucleotides | 13 | 3 | 23.08 |
| 16 | Central intermediary metabolism | 16 | 4 | 25.00 |
Figure 2Percentage of positively and negatively σB-regulated genes in each functional class. Functional classes: 1 = central intermediary metabolism; 2 = purines, pyrimidines, nucleoside, and nucleotides; 3 = amino acid biosynthesis; 4 = cellular processes; 5 = fatty acid and phospholipid metabolism; 6 = cellular proteins; 7 = transporter and binding proteins; 8 = cell envelope; 9 = transcription; 10 = energy metabolism; 11 = hypothetical protein; 12 = biosynthesis of cofactors, prosthetic groups, and carriers; 13 = regulatory functions; 14 = mobile and extrachromosomal element function; 15 = unknown function; and 16 = DNA metabolism.
Figure 3Expression of seven selected genes in both the wild type and ΔsigB mutant determined by qRT-PCR. Differences in mRNA levels of all genes are statistically significant when compared between RF122 wild-type (black) and ΔsigB mutant (white) strains. *significant difference between wild-type and ΔsigB mutant strains at p < 0.05.
Antibiotic susceptibility test of wild type and ΔsigB strain.
| Ampicillin (10 μg) | 32 | S | 35 | S |
| Penicillin G (10 μg) | 38.5 | S | 42 | S |
| Oxacillin (1 μg) | 22 | S | 27 | S |
| Cefoxitin (30 μg) | 25 | S | 30 | S |
| Ceftiofur (30 μg) | 26.5 | S | 30 | S |
| Cephalothin (30 μg) | 36 | S | 41.5 | S |
| Tetracycline (30 μg) | 24 | S | 24 | S |
| Novobiocin (30 μg) | 27.5 | S | 28 | S |
| Trimethoprim–sulfamethoxazole (25 μg) | 23.5 | S | 24 | S |
| Sulfamethoxazole (25 μg) | 15 | I | 15 | I |
| Erythromycin (15 μg) | 20.5 | I | 20.5 | I |
| Streptomycin (10 μg) | 10.5 | R | 10 | R |
The interpretations follow those by the Clinical and Laboratory Standards Institute (CLSI, .
Summary of phenotypic characterization of wild type and ΔsigB mutant.
| Wild type | 2.033 ± 0.419 | 1.668 ± 0.319 | 0.114 ± 0.088 | 0.206 ± 0.140 | 0.306 ± 0.168 | 0.123 ± 0.026 | 0.122 ± 0.024 |
| Δ | 5.670 | 3.614 | 0.211 ± 0.038 | 0.362 ± 0.04 | 0.484 ± 0.095 | 0.140 ± 0.044 | 0.097 |
Statistical differences are reported if p < 0.05.
List of virulence genes affected by σB in this study in comparison to Bischoff et al. (2004).
| Capsular polysaccharide synthesis enzyme | + | + to | |
| Factor essential for expression of methicillin resistance | + | Not reported | |
| Methicillin resistance factor protein | + | N | |
| Hemolysin | + | Not reported | |
| α-Hemolysin precursor | – | – | |
| Enterotoxin G | + | Not reported | |
| Enterotoxin N | + | Not reported | |
| Enterotoxin type C variant | + | Not reported | |
| Coagulase | N | + | |
| Fibrinogen-binding protein | + | Not reported | |
| Clumping factor A | + | + | |
| Lipase | + | – | |
+, positively regulated by σ.